The ADC binds TA-MUC1 on tumor cells, is internalized, and its cleavable linker is degraded in lysosomes to release the DXd topoisomerase I inhibitor, which induces DNA breaks, replication arrest, and apoptosis of TA-MUC1-expressing cells.